Scott Drake

President & CEO
ViewRay, Inc.

Scott Drake is a proven leader in the medical device space. He joined ViewRay as president and CEO in July 2018.

Previously, Drake was president and CEO of Spectranetics, which was acquired by Royal Philips in 2017. At Spectranetics, he increased enterprise value from approximately $190 million to $2.2 billion in six years. Prior to Spectranetics, he spent 17 years in leadership positions within numerous healthcare business units at Covidien, including president of Covidien’s Respiratory and Monitoring Solutions Global Business Unit.

Drake serves as chairman of the board for AtriCure and is also on the board of directors for The Zayo Group Holdings, Inc. He is the chairperson of the AdvaMed Radiation Therapy Sector and a board member for the Medical Device Manufacturers Association. In 2014, Drake was named an Ernst and Young Entrepreneur of the Year.